European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps

Retrieved on: 2025-03-28 13:07:11

Tags for this article:

Click the tags to see associated articles and topics

European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps. View article details on hiswai:

Excerpt

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in July 2025.

Article found on: www.benzinga.com